Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
- A U.S. DISTRICT COURT JUDGES' ROUNDTABLE with the Chief Judges from Delaware, The Northern District of Illinois and New Jersey
- Do not miss your opportunity to hear directly from
- Chief Judges Castillo, Linares, and Stark
- TC HEARTLAND THINK TANK
- Top litigators and leading in house counsel will brainstorm with you on venue and jurisdictional strategies in the aftermath of TC Heartland
- FOCUS GROUP ON OIL STATES AND SAS
- You will have the opportunity to hear from those "in the know" as well as join the discussion on these two pivotal pending Supreme Court decisions and their possible consequences on the future of IPRs
- 4 FTC KEYNOTE
- Markus Meier will provide insights on the latest anti-trust developments affecting Paragraph IV litigation
- TWO NEW CONFERENCE TRACKS that will contemplate:
- The Business of Pharmaceutical Patent Litigation; and
- The Practice of Pharmaceutical Patent Litigation